홈 › 동맥경화증 › 텍사스

텍사스의 동맥경화증 임상 시험

동맥경화증 관련 연구 11개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Southwest Family Medicine Associates, Dallas
East Texas Cardiology PA, Houston
Cardiovascular Specialists of Willowbrook, Houston
외 1개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

PharmaTex Research, Amarillo
St. David's Heart & Vascular PLLC dba Austin Heart, Austin
Velocity Clinical Research, Austin, Austin
외 18개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07157774

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

PharmaTex Research, LLC, Amarillo
Pulse Care Heart and Vascular, Carrollton
DM Clinical Research - Dallas, Tomball

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07521007

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
외 2개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07783802

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Velocity Clinical Research - Austin, Austin
외 22개

피험자 모집 중3상

45세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Cussimanio Research Group LLC, Austin
Research Management, Inc., Austin
MW Clinical Research Center, Beaumont
외 22개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Amarillo
Research Site, Beaumont
Research Site, Brownsville
외 33개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

PharmaTex Research LLC, Amarillo
Kelsey Seybold Research Foundation, Houston
Northwest Houston Clinical Research PLLC, Tomball

피험자 모집 중3상

18세 ~ 80세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06813911

Pelacarsen Roll-over Extension Program

Plano Primary Care Clinic, Allen
Pharma Tex Research, Amarillo
SW Family Medicine Associates, Dallas
외 8개

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston

피험자 모집 중4상

18세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

UT Health Houston, Houston

피험자 모집 중2상

40세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT05488431

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.